ScrutarSign up free

HEALTHPEAK PROPERTIES, INC. (DOC)

SEC filings, insider trading & institutional ownership from EDGAR.

NYSEFinancialsFinancial Services

Healthpeak Properties, Inc. is an S&P 500 self-administered REIT, originally founded in 1985 and organized as a Maryland corporation, that acquires, develops, owns, leases, and manages healthcare real estate across the United States. Headquartered in Denver, Colorado, with additional offices in California, Tennessee, and Massachusetts, the company refocused its strategy in 2021 after divesting its senior housing triple-net and senior housing operating property (SHOP) portfolios, both classified as discontinued operations, to concentrate on three core asset classes: life science, medical office, and continuing care retirement community (CCRC) real estate. As of December 31, 2022, Healthpeak held interests in 480 properties, including 149 life science properties (50% of Total Portfolio Adjusted NOI), 297 medical office properties including nine hospitals (39%), and 15 CCRC properties operated through RIDEA structures (9%), plus other non-reportable investments (2%) including loans receivable, marketable debt securities, and a joint venture (SWF SH JV) owning 19 senior housing assets.

Life science properties, concentrated in San Francisco, San Diego, and Boston, are largely triple-net leased (92%) to biotechnology, pharmaceutical, and research tenants, with Amgen as a notable tenant. Medical office buildings, 65% triple-net leased, are predominantly located on or near hospital campuses (87%) and affiliated with hospital systems (98%), with HCA Healthcare as a major tenant. CCRCs, operated under RIDEA structures via third-party manager-operators, provide a continuum of care including independent living, assisted living, memory care, and skilled nursing, primarily funded by private pay sources rather than government reimbursement.

The company's strategy rests on four pillars: high-quality real estate in desirable, purposely selected private-pay asset classes; a strong investment-grade balance sheet with staggered, long-term fixed-rate debt; partnerships with leading pharmaceutical, biotechnology, and healthcare operators; and a platform emphasizing talent and operational efficiency. Growth is pursued through internal strategies (tenant relationship management, lease renewals, and re-tenanting) and external strategies (acquisitions, development, and redevelopment), financed through operating cash flow, asset sales, credit facilities, debt issuances, and equity offerings, consistent with REIT distribution requirements. The company operates in a highly competitive and heavily regulated environment, with tenants and operators subject to extensive healthcare laws covering licensure, fraud and abuse, privacy (HIPAA), reimbursement programs (Medicare/Medicaid), certificate of need requirements, entrance fee regulations for CCRCs, ADA compliance, and environmental laws.

In February 2023, Healthpeak announced a corporate reorganization into an UPREIT structure via a merger agreement with New Healthpeak, Inc. and Healthpeak Merger Sub, Inc., after which the company will convert to a Maryland limited liability company (Healthpeak OP, LLC), with New Healthpeak becoming the renamed parent entity; the transaction does not require stockholder approval and will not alter the company's consolidated assets, liabilities, or business operations. The company also maintains various insurance programs and has established ESG initiatives overseen by its Board of Directors, reporting a 3.4% reduction in Scope 1 and 2 greenhouse gas emissions in 2021 and obtaining new LEED and ENERGY STAR certifications in 2022.

AI-summarized from Item 1 (Business) of the company's most recent 10-K filing.

RevenueFY2025
$2.82B
▲ 4.5%YoY
Net incomeFY2025
$101.03M
▼ 62.2%YoY
Diluted EPSFY2025
$0.10
▼ 72.2%YoY
Insider net6 mo
+63.8K
shares1 sells0 buys
Institutions
42
$9.31B held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
$1B$2B$3B
FY2022FY2023FY2024FY2025
RevenueNet income
FY2025 highlightsfrom 10-K
Diluted EPS$0.10
Net margin3.6%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
SC 13GSTATE STREET CORPORATIONAug 7, 2026EDGAR
10-QAug 5, 2026EDGAR
8-KAug 4, 2026EDGAR
SC 13G/AamendedJPMORGAN CHASE & COJul 22, 2026EDGAR
4Thomas John TJun 2, 2026EDGAR
4Patadia Ankit B.Jun 2, 2026EDGAR
4Moses Kelvin OJun 2, 2026EDGAR
4Mabry Adam GJun 2, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
Brinker Scott MMay 29, 2026Tax withholding
Brinker Scott MMay 29, 2026Grant / award
Mabry Adam GMay 29, 2026Tax withholding
Mabry Adam GMay 29, 2026Grant / award
Moses Kelvin OMay 29, 2026Tax withholding

Top holders

13F & 13D/G · latest quarter

All →
HolderStakeFiledValue
BlackRock, Inc.10.3%Aug 7, 2026$1.52B
Vanguard Portfolio Management8.5%Aug 13, 2026$1.25B
Vanguard Capital Management6.5%Aug 13, 2026$963.32M
STATE STREET CORPORATION6.4%Aug 7, 2026$941.76M
JPMORGAN CHASE & CO4.4%Aug 12, 2026$661.02M

DOC's filings are public. The insight is one click away.

Scrutar's AI reads every DOC filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze DOC filingsNo credit cardAI reports included on the free plan

Never miss a DOC filing.

Get an email when DOC files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Sep 14, 2026Source: SEC EDGAR.